Active Ingredient(s): Levocabastine
FDA Approved: * November 10, 1993
Pharm Company: * NOVARTIS
Category: Allergies, Cough & Cold

Levocabastine (trade name Livostin or Livocab, depending on the region) is a selective second-generation H1 receptor antagonist which was discovered at Janssen Pharmaceutica in 1979. It is used for allergic conjunctivitis.[3] As well as acting as an antihistamine, levocabastine has also subsequently been found to act as a potent and selective antagonist for the neurotensin receptor NTS2, and was the first drug used to characterise the different neurotensin subtypes.[4&... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.